Laura Coates outlines the findings from a phase 3b trial of guselkumab versus placebo in patients with psoriatic arthritis and an inadequate response to TNF inhibitors (6:03).
View more on Medicine Matters rheumatology: bit.ly/2U6Vxhi
Негізгі бет COSMOS: Further evidence for the benefits of guselkumab in PsA | Laura Coates
No video
Пікірлер